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Hypertension is a degenerative disease whose prevalence is high and continues to increase over 
time. Polyherbal tablet have long been used by Indonesian people for hypertension drugs containing garlic 
(Alium sativum), jelawe (Belericae fructus), temu ireng rhizomes (Curcumae aeruginosae) and kapulaga 
(Amomi fructus) extracts. This study aims to determine the effect of polyherbal tablet on hypertensive 
patients. The subjects of 29 hypertensive patients participated in a open-randomized-without comparison-
study for 6 weeks. Subjects were divided into 3 groups, each subject received polyherbal tablet with a dose 
of 2x600 mg (group 1), 2x1200 mg (group 2) and 2x2400 mg (group 3). Blood pressure was monitored on 
D-0, D-3, D-5, D-7, W-2, W-3, W-4, W-5 and W-6. There was a significant decrease in systolic and diastolic 
blood pressure at the sixth week in all three treatment groups. The highest decrease in systolic blood 
pressure was in group 1 while diastolic blood pressure was in group 2 (-22.94 ± 5.871 and 13.13 ± 4.324 
respectively). The lowest reduction in systolic and diastolic blood pressure occurred in the third group (-
15.07 ± 3,519 and 8.98 ± 3,394 respectively). This study suggests that polyherbal tablet contains garlic (Alii 
sativi), jelawe (Belericae Fructus), temu ireng rhizome (Curcumae aeruginosae) and cardamom (Amomi 
Fructus) can reduce blood pressure in patients with hypertension.  
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INTRODUCTION  
Hypertension is one of the global burdens of 
disease, with patients diagnosed with 
hypertension worldwide reaching 1 billion people 
in 2008 and it is estimated that it will continue to 
increase every year (WHO, 2013). Uncontrolled 
hypertension will cause several serious 
complications, namely myocardial infarction, 
stroke, renal failure and death (James et al., 2104). 
In addition to controlling risk factors such as 
obesity, physical inactivity and low salt diets, 
hypertension control strategies are focused on the 
administration of antihypertensive therapy 
(Rahimi et al., 2015) 
One of several herbal medicines to treat 
hypertension in Indonesia is polyherbal tablet. 
Polyherbal tablet contain garlic (Alii sativi), jelawe 
(Belericae fructus), temu ireng (Curcumae 
aeruginosae) and cardamom (Amomi fructus) 
extracts. Garlic (Alii sativi) has been widely used to 
treat various cardiovascular disorders. The results 
showed that garlic can reduce the blood pressure 
of hypertensive patients better than placebo (Ried 
et al.,  2016; Wang et al., 2015).  Belericae fructus 
(Terminalia bellerica) has antioxidant and 
antihypertensive effects (Khan AU and Gilani AH, 
2008; Chavan et al., 2010). Antioxidant activity is 
also   possessed   by   Curcumae   aeruginosae   and  
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Amomi fructus (Choudhury et al., 2013; Nurcholis 
et al., 2015; Guo et al., 2008). Oxidative stress is the 
main mechanism in endothelial dysfunction and 
vascular damage, which has been known to play an 
important role in the pathogenesis of hypertension 
(Baradaran et al., 2014; Guzik and Touyz, 2017). 
Research has been conducted on the effectiveness 
of polyherbal tablet and the results show that 
polyherbal tablet a dose of 252 mg/kgBB 
(equivalent to the dose in humans) can reduce the 
blood pressure of mice in the hypertension model 
(Ngatidjan and Nugrahaningsih, 2016). So the 
purpose of this study is to determine the effect of 
polyherbal tablet in hypertensive patients.  
 
METHODOLOGY 
This study has received appropriate ethical 
approval (Number: KE/FK/0234/EC/2018) from 
the Medical and Health Research Ethics 
Commission of the Faculty of Medicine, Public 
Health and Nursing, Gadjah Mada University. The 
subjects of this study were hypertensive patients 
who had never been treated or who had been 
treated but had not taken medicine for 2 weeks or 
more with the inclusion criterias are adult, male 
and female, aged between 20-60 years; meet 
criteria for diagnosing hypertension stage 1 
according to JNC 8 (TDS 140-159 or TDD 90-99 
mmHg); new or stage 1 hypertensive patients 
which within 14 days before recruitment do not 
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take antihypertensive drugs or herbs intended to 
reduce blood pressure; willing to take part in the 
study by signing an informed consent. Patients 
who are pregnant / lactating women, have a 
history of diabetes, a history of heart disease, liver 
function abnormalities (SGOT and / or SGPT> 3 
times the upper limit of normal values), abnormal 
kidney function (urea and / or creatinine> 3 
mg/dl), Polyherbal tablet hypersensitivity / 
intolerance was excluded.  
This study is randomized, open-trial, 
without comparison. Subjects were divided into 3 
groups, each subject received polyherbal tablet 2 
times a day with polyherbal tablet doses of 2 x 
600mg (group 1), 2 x 1200mg (group 2) and 2 x 
2400mg (group 3) for 6 weeks. Doses can be 
titrated according to blood pressure when 
monitoring measurements in D1, D3, D5, D7, W2, 
W3, W4, W5 and W6. The daily dose range of 
polyherbal tablet are 1200 - 4800 mg/d. 
Polyherbal tablets preparations in tablet form 
were prepared by PT Marguna Tarulata APK Farma 
with 600 mg strength. The subjects would get the 
tablets gradually along with blood pressure 
measurement. polyherbal tablet is taken twice 
with an interval of 12 h. The tablets taken at the 
same time which is between 07.00-09.00 and 
19.00-21.00, before or after meals. Subjects who 
meet the criteria to respond to therapy, they would 
receive a tablet of 7 d to week 6. During the study, 
subjects were required to consult other drugs 
(including OTC) consumed to the researcher.    
Other drugs that can be consumed were drugs that 
do not affect the subject's blood pressure. All drugs 
consumed by the subjects were recorded and 
reported. 
Examinations were carried out include vital 
sign examinations, basic physical examinations, 
ECG and laboratory examinations. Vital sign 
examination was carried out by paramedics in 9 
times on D-0 (day 0), D-3, D-5, D-7, W-2, W-3, W-4, 
W-5 and W-6. Vital sign examination included 
examination of blood pressure, body temperature, 
pulse rate and respiratory rate. Blood pressure 
examination used a calibrated Standard                 
adult size nylon aneroid sphygmomanometer. 
Measurements were performed at the position 
after the subject has sat quiet for at least 5 minutes 
in the chair and performed 2 measurements on the 
left arm that is parallel to the heart. The value 
obtained was the average of 2 measurements.      
The basic physical examination was carried out by 
the doctor, each subject was examined twice, at D-
0 and W-6. Physical examinations included 
examination of the cardiovascular, respiratory, 
gastrointestinal, dermatological, musculosceletal 
and nervous systems; examination of height and 
weight. Each subject received an ECG examination 
twice on D-0 and W-6. Laboratory tests included 
routine blood test, SGOT, SGPT, ureum and 
creatinine which were also carried out twice on D-
0 and W-6. 
 
RESULT AND DISCUSSION  
The study was conducted in Plosokuning, 
Kayen, Kancilan, and Babadan DI Yogyakarta. Of 
the 64 people with hypertension during screening, 
29 subjects met the inclusion criteria (Figure 1). 
Ten subjects were allocated in group 1 and group 
2. Only 9 subjects is randomized into group 3.       
One subject from group 1 dropped out (DO) at the 
beginning  of  taking  the drug because of headache 
 
Figure 1. Trial flow chart 
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complaint, 2 subjects from group 2 dropped out at 
the beginning of drug consumption and at day 5 
because they complained of nausea, and 2 subjects 
from group 3 dropped out at the beginning of drug 
consumption and during the third week because 
they complained of nausea and decided not to 
continue the study. So that the number of subjects 
analyzed at the end of the study were 24 subjects. 
Baseline characteristics did not differ 
significantly between treatment groups, including 
age, BMI and blood test parameters. Based on the 
BMI value of the participants, most of the 
participant was included in the overweight 
category with BMI average of 24.96 ± 4.21.              
The average of total cholesterol, LDL and HDL in 
groups 1, grup 2 and grup 3 were 206.58 ± 26.02, 
55.71 ± 11.89, and 136.75 ± 23.99 respectively 
(Table I). These data shows that most of the 
participant has dyslipidemia. 
The mean blood pressure reduction from 
baseline compared to the end of the study (week 6) 
is presented in Table II. All groups showed a 
significant decrease in systolic blood pressure.     
The highest Systolic Blood Pressure decrease was 
seen in the group 1. Diastolic blood pressure 
decreased significantly only in the group 1 and 2. 
The highest reduction in diastolic blood pressure 
was found in group 2. Figure 2 shows the mean 
blood pressure for each measurement. Eventhough 
the systolic blood pressure decreased in all three 
groups, systolic blood pressure in the third group 
did not reach the normal blood pressure value until 
the end of the study. 
Our study showed that polyherbal tablet 
containing Alium sativum, Belericae fructus, 
Curcuma aeruginosa, dan Amomi fructus can 
reduce systolic blood pressure by an average of 20 
mmHg and diastolic blood pressure by 10 mmHg. 
There was a significant decrease in systole blood 
pressure in the all groups and diastolic blood 
pressure in group 1 and 2. The difference of mean 
systolic and diastolic blood pressure reduction 
were not statistically significant among the three 
groups (p = .632 and p = .231 respectively). Grup 1 
that received 2 x 600 mg tablet showed the highest 
decrease in systolic blood pressure. During the 
study, the subjects in the group 1 whom blood 
pressure fail to reach the normal value,                          
the polyherbal dose was increased to a dose of 2 
x1200 mg. This shows that the group 2 dose 
actually has a better blood pressure reduction 
effect than dose 1. This result is in accordance with 
the results of preclinical study on hypertensive 
animal models (Ngatidjan and Nugrahaningsih, 
2016). In preclinical study, blood pressure was the 
lowest at the group treated with the dose that 
equal to the dose used in group 2 of the present 
study. 
Polyherbal tablet used in this study contains 
garlic (Alii sativi), jelawe (Belericae Fructus), temu 
ireng rhizome (Curcumae aeruginosae) and 
cardamom (Amomi Fructus) extracts. Several 
meta-analyzes showed that garlic can reduce blood 
pressure in patients with hypertension (Ried, 
2014; Xiong et al., 2015). Effects of blood pressure 
reduction by garlic with a dose range of 240-       
2400  mg  can  reduce   systolic   blood  pressure  by 
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8.35 mmHg and diastolic pressure by 6.1 mmHg 
(Ried, 2014). The garlic active compound which is 
suggested to have antihypertensive effects are s-
allylcysteine, allicin, allyl methyl sulfide (AMS) and 
diallyl sulfide (DAS). The garlic antihypertensive 
action is suggested due to its antioxidant activity 
by trapping reactive oxygen species such as O2- and 
H2O; inhibiting the activity of NADPH oxidase; and 
increasing the activity of superoxide dismutase 
(potent antioxidant). Besides the hypotensive 
effect of garlic also through inhibiting of Na+ 
channel activity, suppresing NFκB expression 
thereby reducing atherosclerosis, triggering the 
production of H2S which functions as a vasodilator, 
inhibiting ACE, and inhibiting Angiotensin II-
induced cell cycle production from vascular 
smooth muscle cells (Hosseini and Hosseinzadeh, 
2015; Ried and Fakler, 2014; Shouk et al., 2014). 
Belericae fructus or jelawe is thought to have 
antihypertensive   effects    through    inhibition    of  
Table I. Baseline characteristics 
 
Characteristics 
All Subjects * 
(n = 24) 
Group 1 (n = 9) Group 2 (n = 8) Group 3 (n = 7) 
Gender (m/f) 1/23 0/9 0/8 1/6 
History of 
smoking (n/%) 
1/4 0/0 0/0 1/14 






















































































































































Abbreviations: BMI, body mass index; f, female; Hb, hemoglobin; HDL, high-density lipoprotein; LDL, low-
density lipoprotein; m, male; RBC, red blood cells count, SD, standard deviation; SGOT, serum glutamic 
oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; TC, total cholesterol; TG, 
triglycerides; WBC, white blood cells count. 
* no significant differences between groups 
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Ca2 + influx on calcium channels and through its 
antioxidant effects. Research conducted by 
Namphootiri et al (2011) showed that Belericae 
fructus has antioxidant activity and radical 
scavenging in DPPH, superoxide and hydroxy 
radical due to its gallic acid and ferulic acid content. 
Curcuma aeruginosa and Amomi fructus also have 
antioxidant effects (Nurcholis et al., 2015; Guo et 
al., 2008). Study conducted by Moon-ai et al (2012) 
of 15 Zingiberaceae plants showed that Curcuma 
aeruginosa had a significant superoxide dismutase 
activity. Whereas Amomi fructus has DPPH radical 
scavenging activity and ferric reducing antioxidant 
power (FRAP) which can scavenging free radical 
and reduces prooxidants (Guo et al., 2008). 
Oxidative stress is the main mechanism in 
endothelial dysfunction and impaired vascular 
relaxation, which has been known to play an 
important role in the pathogenesis of 
hypertension. So that antioxidants administration 
is hypothesized to function as a vascular protector 
(Siti et al., 2015). 
The treatment with highest dose of the 
poliherbal(Polyherbal tablet 2x2400 mg) showed 
the lowest reduction in blood pressure. This result 
is also in accordance with studies in rat, that 
showed that at the highest doses the decrease of 
the blood pressure was not better than lower dose. 
It might be caused by the antioxidant effect of the 
compound in the polyherbal. In the high dose, the 
antioxidant can be converted into prooxidant and 
loss it protective effect (Bouayed and Bohn, 2010; 
Suru and Ugwu 2015). 
 
CONCLUSION 
The polyherbal tablet contains garlic (Alii 
sativi), jelawe (Belericae Fructus), temu ireng 
rhizome (Curcumae aeruginosae) and cardamom 
(Amomi Fructus) can reduce blood pressure in 
patients with hypertension. 
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